Sandesh Seth
Chief Executive Officer at Actinium Pharmaceuticals Inc. (Delaware)
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Actinium Pharmaceuticals Inc. (Delaware), 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Actinium Pharmaceuticals Inc. (Delaware) November 27, 202477.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Actinium Pharmaceuticals Inc. (Delaware) | Grant or award | +753,600 | — | — |
| Sep 2, 2026 | Actinium Pharmaceuticals Inc. (Delaware) | Grant or award | +1,027,274 | — | — |
| Aug 18, 2025 | Actinium Pharmaceuticals Inc. (Delaware) | Shares withheld for tax | −120,900 | $1.71 | $206,739 |
Questions about Sandesh Seth
What boards is Sandesh Seth on?
Sandesh Seth sits on the board of Actinium Pharmaceuticals Inc. (Delaware).
What company is Sandesh Seth the CEO of?
Sandesh Seth is Chief Executive Officer of Actinium Pharmaceuticals Inc. (Delaware).
How long has Sandesh Seth served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.